| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/13/2007 | US7176305 Overdrying 5'-guanylic acid disodium crystals, 5'-inosinic acid disodium crystals, and mixture containing the alcohol, contacting the mixture with hdrophilic organic solvent to control the humidity |
| 02/13/2007 | US7176296 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 02/13/2007 | US7176191 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 02/13/2007 | US7176011 Lipid cleavage enzyme |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/13/2007 | CA2123241C Nucleosides and oligonucleotides having 2'ether groups |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/08/2007 | WO2007015257A2 A process for the preparation of gemcitabine using novel intermediates |
| 02/08/2007 | US20070032645 Synthesis of cladribine |
| 02/08/2007 | US20070032448 Sugar modified nucleosides as viral replication inhibitors |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032407 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070031824 Simultaneous quantification of nucleic acids in diseased cells |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/07/2007 | EP1749016A2 Adenosine receptor agonists |
| 02/07/2007 | EP1601785A4 Methods for detection of genetic disorders |
| 02/07/2007 | CN1910194A Synthesis of spongosine |
| 02/07/2007 | CN1910193A Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 02/07/2007 | CN1907996A Method of separating and purifying adenomethionine |
| 02/06/2007 | US7173125 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173017 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 02/06/2007 | US7173016 Composition and method for treating graft-versus-host disease |
| 02/01/2007 | WO2007012494A1 Stable nad/nadh derivatives |
| 02/01/2007 | WO2007012177A1 Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy |
| 02/01/2007 | WO2005026184A3 Synthesis and compositions of 2'-terminator nucleotides |
| 02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
| 02/01/2007 | US20070027104 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/01/2007 | US20070027095 Using nicotinamide riboside-related prodrug for treatment and prevention of cell proliferative disorders |
| 02/01/2007 | US20070027066 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/01/2007 | US20070027065 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/01/2007 | US20070026476 Compounds, methods, complexes, apparatuses and uses relating to stabile forms of nad/nadh |
| 02/01/2007 | US20070026410 Nucleoside cyanine dye derivatives for RNA labeling and nucleic acid detection and methods for using same |
| 02/01/2007 | DE102006035020A1 Test element for determining analytes, comprises stabilized coenzyme and coenzyme-dependent enzyme, used especially for determination of glucose |
| 02/01/2007 | CA2737123A1 Stable nad/nadh derivatives |
| 02/01/2007 | CA2617063A1 Assays for resistance to echinocandin-class drugs |
| 02/01/2007 | CA2616592A1 Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy |
| 01/31/2007 | CN1903869A Tibifudine derivative salt and its preparation method and pharmaceutical application |
| 01/31/2007 | CN1297565C Method for preparing 2',3'2-dideoxycytidine |
| 01/30/2007 | US7169939 Linkers for donor dyes to acceptor dyes for energy transfer between dyes with fluorescence |
| 01/30/2007 | US7169918 chemical intermediates used to prepare nucleosides, useful in treating viral infections caused by flaviviruses, such as hepatitis virus |
| 01/30/2007 | US7169766 Administering nucleoside, or prodrug thereof; viricides |
| 01/30/2007 | US7169765 Acyl derivatives of 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxythymidine; for treating or preventing radiation, mutagen and sunlight-induced biological damage, and improving wound healing and tissue repair |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | US7169557 Universal nucleotides for nucleic acid analysis |
| 01/30/2007 | US7169556 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/30/2007 | US7169553 2-Azapurine compounds and their use |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/25/2007 | WO2007010515A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 01/25/2007 | WO2007009757A1 Purine derivatives as agonists of the adenosine a2a receptor |
| 01/25/2007 | WO2007009303A1 Process for synthesizing n4-acyl-5'-deoxy-5-fluorocytidine derivatives |
| 01/25/2007 | US20070021388 trans-stereochemistry to improve half life, oral bioavailability and activity; liver disorderslike liver cancer, liver infections, fibrosis, obesity; trans-4-(3-chlorophenyl)-2-(4-nitrophenoxy)-2-oxo-1,3,2-dioxaphosphorinane |
| 01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 01/25/2007 | CA2615980A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 01/25/2007 | CA2615356A1 Homogemcitabines |
| 01/24/2007 | EP1745573A2 METHODS OF MANUFACTURE OF 2 -DEOXY-&bgr;-L-NUCLEOSIDES |
| 01/24/2007 | EP1745061A1 Novel amphiphilic compounds, preparation method thereof and applications of same |
| 01/24/2007 | EP1334111A4 Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| 01/24/2007 | CN1901931A HIV gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 01/24/2007 | CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 01/24/2007 | CN1900103A Nucleoside phosphoramidite used in RNA oligo-nucleotide synthesis and its synthesizing method |
| 01/23/2007 | US7166718 Calix[4]arene-nucleoside and calix[4]oligonucleotide hybrids |
| 01/23/2007 | US7166715 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166581 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/23/2007 | US7166478 Cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; useful for labeling probes or targets, including nucleic acids and proteins |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/18/2007 | WO2006108678A3 New s-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases |
| 01/18/2007 | WO2004072297A3 Terminal-phosphate-labeled nucleotides and methods of use |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | US20070015914 Stereoselective synthesis of beta-nucleosides |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
| 01/18/2007 | US20070015725 2-azapurine compounds and their uses |
| 01/18/2007 | DE102006012317A1 New macromolecular compounds comprising nucleotide and nucleoside building blocks, are useful in enzymatic reactions and nucleic acid analysis |
| 01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
| 01/17/2007 | CN1896089A Synthesis of N-acyl-5'-desoxy-5-flucytogly derivative |
| 01/17/2007 | CN1295243C Method for preparing beta-thymidine |
| 01/17/2007 | CN1295242C 3'-prodrugs of 2'-deoxy-beta-L-nucleosides |
| 01/17/2007 | CN1295241C Process for producing a ribofuranose |
| 01/16/2007 | US7164014 Used to produce amino- modified linkers that space an oligonucleotide from a solid support |
| 01/16/2007 | US7163929 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/16/2007 | US7163928 Partial and full agonists of A1 adenosine receptors |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007004230A2 A novel process for the preparation of didanosine using novel intermediates |
| 01/11/2007 | WO2006117161A3 New labelling strategies for the sensitive detection of analytes |
| 01/11/2007 | WO2006113615A3 Anti-microbial agents and uses thereof |
| 01/11/2007 | US20070009889 Nucleoside derivative, modifed oligonucleotide, method for their syntesis and applicantions thereof |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | EP0782580B1 Parallel selex |
| 01/10/2007 | CN1891710A L-nucleoside prodrug |
| 01/10/2007 | CN1293943C Catalyst for preparing isoamyl acetate and preparation method thereof |
| 01/09/2007 | USRE39464 Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/09/2007 | US7160999 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 01/09/2007 | US7160867 Rapamycin carbohydrate derivatives |
| 01/09/2007 | US7160537 Preparation of [18F]-fluoro-3'-deoxy-3'-L-fluorothymidine by fluorinating a Boc-protected 3'-deoxythymidine substituted in the 3' position with a leaving group and removing the amine protecting group |
| 01/09/2007 | CA2227533C Improved therapeutic agents |
| 01/04/2007 | US20070004911 Silylated oligonucleotide compounds |